- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 48 x CA: CALCIUM ION(Non-covalent)
- 80 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 4 residues within 4Å:- Chain A: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.5: 1 residues within 4Å:- Chain A: N.156
Ligand excluded by PLIPNAG.6: 4 residues within 4Å:- Chain A: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain A: R.851, N.856
Ligand excluded by PLIPNAG.8: 2 residues within 4Å:- Chain A: N.1146, P.1150
Ligand excluded by PLIPNAG.12: 4 residues within 4Å:- Chain B: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.13: 1 residues within 4Å:- Chain B: N.156
Ligand excluded by PLIPNAG.14: 4 residues within 4Å:- Chain B: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain B: R.851, N.856
Ligand excluded by PLIPNAG.16: 3 residues within 4Å:- Chain B: R.1144, N.1146, P.1150
Ligand excluded by PLIPNAG.20: 4 residues within 4Å:- Chain C: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain C: N.156
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain C: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain C: R.851, N.856
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain C: N.1146, P.1150
Ligand excluded by PLIPNAG.28: 4 residues within 4Å:- Chain D: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.29: 1 residues within 4Å:- Chain D: N.156
Ligand excluded by PLIPNAG.30: 4 residues within 4Å:- Chain D: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain D: R.851, N.856
Ligand excluded by PLIPNAG.32: 3 residues within 4Å:- Chain D: R.1144, N.1146, P.1150
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain E: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain E: N.156
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain E: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain E: R.851, N.856
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain E: N.1146, P.1150
Ligand excluded by PLIPNAG.44: 4 residues within 4Å:- Chain F: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain F: N.156
Ligand excluded by PLIPNAG.46: 4 residues within 4Å:- Chain F: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain F: R.851, N.856
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain F: R.1144, N.1146, P.1150
Ligand excluded by PLIPNAG.52: 4 residues within 4Å:- Chain G: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.53: 1 residues within 4Å:- Chain G: N.156
Ligand excluded by PLIPNAG.54: 4 residues within 4Å:- Chain G: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain G: R.851, N.856
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain G: N.1146, P.1150
Ligand excluded by PLIPNAG.60: 4 residues within 4Å:- Chain H: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.61: 1 residues within 4Å:- Chain H: N.156
Ligand excluded by PLIPNAG.62: 4 residues within 4Å:- Chain H: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.63: 2 residues within 4Å:- Chain H: R.851, N.856
Ligand excluded by PLIPNAG.64: 3 residues within 4Å:- Chain H: R.1144, N.1146, P.1150
Ligand excluded by PLIPNAG.68: 4 residues within 4Å:- Chain I: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.69: 1 residues within 4Å:- Chain I: N.156
Ligand excluded by PLIPNAG.70: 4 residues within 4Å:- Chain I: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.71: 2 residues within 4Å:- Chain I: R.851, N.856
Ligand excluded by PLIPNAG.72: 2 residues within 4Å:- Chain I: N.1146, P.1150
Ligand excluded by PLIPNAG.76: 4 residues within 4Å:- Chain J: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.77: 1 residues within 4Å:- Chain J: N.156
Ligand excluded by PLIPNAG.78: 4 residues within 4Å:- Chain J: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.79: 2 residues within 4Å:- Chain J: R.851, N.856
Ligand excluded by PLIPNAG.80: 3 residues within 4Å:- Chain J: R.1144, N.1146, P.1150
Ligand excluded by PLIPNAG.84: 4 residues within 4Å:- Chain K: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.85: 1 residues within 4Å:- Chain K: N.156
Ligand excluded by PLIPNAG.86: 4 residues within 4Å:- Chain K: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.87: 2 residues within 4Å:- Chain K: R.851, N.856
Ligand excluded by PLIPNAG.88: 2 residues within 4Å:- Chain K: N.1146, P.1150
Ligand excluded by PLIPNAG.92: 4 residues within 4Å:- Chain L: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.93: 1 residues within 4Å:- Chain L: N.156
Ligand excluded by PLIPNAG.94: 4 residues within 4Å:- Chain L: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.95: 2 residues within 4Å:- Chain L: R.851, N.856
Ligand excluded by PLIPNAG.96: 3 residues within 4Å:- Chain L: R.1144, N.1146, P.1150
Ligand excluded by PLIPNAG.100: 4 residues within 4Å:- Chain M: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.101: 1 residues within 4Å:- Chain M: N.156
Ligand excluded by PLIPNAG.102: 4 residues within 4Å:- Chain M: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.103: 2 residues within 4Å:- Chain M: R.851, N.856
Ligand excluded by PLIPNAG.104: 2 residues within 4Å:- Chain M: N.1146, P.1150
Ligand excluded by PLIPNAG.108: 4 residues within 4Å:- Chain N: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.109: 1 residues within 4Å:- Chain N: N.156
Ligand excluded by PLIPNAG.110: 4 residues within 4Å:- Chain N: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.111: 2 residues within 4Å:- Chain N: R.851, N.856
Ligand excluded by PLIPNAG.112: 3 residues within 4Å:- Chain N: R.1144, N.1146, P.1150
Ligand excluded by PLIPNAG.116: 4 residues within 4Å:- Chain O: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.117: 1 residues within 4Å:- Chain O: N.156
Ligand excluded by PLIPNAG.118: 4 residues within 4Å:- Chain O: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.119: 2 residues within 4Å:- Chain O: R.851, N.856
Ligand excluded by PLIPNAG.120: 2 residues within 4Å:- Chain O: N.1146, P.1150
Ligand excluded by PLIPNAG.124: 4 residues within 4Å:- Chain P: F.97, N.99, T.101, R.108
Ligand excluded by PLIPNAG.125: 1 residues within 4Å:- Chain P: N.156
Ligand excluded by PLIPNAG.126: 4 residues within 4Å:- Chain P: N.666, P.691, L.693, Y.694
Ligand excluded by PLIPNAG.127: 2 residues within 4Å:- Chain P: R.851, N.856
Ligand excluded by PLIPNAG.128: 3 residues within 4Å:- Chain P: R.1144, N.1146, P.1150
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Anderson, J.R. et al., Structures of VWF tubules before and after concatemerization reveal a mechanism of disulfide bond exchange. Blood (2022)
- Release Date
- 2022-07-06
- Peptides
- von Willebrand factor: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-16-mer
- Ligands
- 48 x CA: CALCIUM ION(Non-covalent)
- 80 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Anderson, J.R. et al., Structures of VWF tubules before and after concatemerization reveal a mechanism of disulfide bond exchange. Blood (2022)
- Release Date
- 2022-07-06
- Peptides
- von Willebrand factor: ABCDEFGHIJKLMNOP
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
LM
MN
NO
OP
P